Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis

Nanomedicine Approaches for the Pulmonary Treatment of Cystic Fibrosis

Cystic fibrosis (CF) is a genetic disease affecting today nearly 70,000 patients worldwide and characterized by a hypersecretion of thick mucus difficult to clear arising from the defective CFTR protein. The over-production of the mucus secreted in the lungs, along with its altered composition and c...

Full description

Bibliographic Details
Main Authors: Cecilia Velino, Francesca Carella, Alessio Adamiano, Maurizio Sanguinetti, Alberto Vitali, Daniele Catalucci, Francesca Bugli, Michele Iafisco
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
cystic fibrosis
nanoparticles
drug delivery
gene therapy
lung pathology
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2019.00406/full

Internet

https://www.frontiersin.org/article/10.3389/fbioe.2019.00406/full

Similar Items